Pregled bibliografske jedinice broj: 1102378
Investigation of the newly characterized baimantuoluoamide A and baimantuoluoamide B alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations
Investigation of the newly characterized baimantuoluoamide A and baimantuoluoamide B alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations // Journal of molecular structure, 1230 (2021), 129925, 8 doi:10.1016/j.molstruc.2021.129925 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1102378 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Investigation of the newly characterized
baimantuoluoamide A and baimantuoluoamide B
alkaloids as potential cyclin-dependent kinase 4
(CDK4) inhibitors using molecular docking and
molecular dynamics simulations
Autori
Gurushankar, Krishnamurti ; Rimac, Hrvoje ; Potemkin, Vladimir ; Grishina, Maria
Izvornik
Journal of molecular structure (0022-2860) 1230
(2021);
129925, 8
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
D. stramonium ; D. metel L ; Baimantuoluoamide A ; Baimantuoluoamide B ; ChemoSophia ; CDK4 ; MM/GBSA ; 3D/4D QSAR ; Molecular Dynamics ; Molecular Docking
Sažetak
CDK4 is an enzyme often associated with various forms of cancer. Since an abnormal function of the CDK4-cyclin D1 protein complex can play a pivotal role in causing various types of cancer, CDK4 is considered an important therapeutic target. Traditionally, herbal medicines have played a vital role in the treatment of many diseases and ailments. Likewise, D. stramonium, Solanaceae, possesses the cytotoxic, anti-inflammatory, anti- viral, antibacterial, antioxidant, analgesic, antiulcer, and insecticidal properties which are a result of its phytoconstituents. Baimantuoluoamide A and baimantuoluoamide B are newly isolated Datura metel L. phytoconstituents, whose molecular interactions are still unknown. Additionally, an experimentally determined crystal structure of baimantuoluoamide A and baimantuoluoamide B bound to CDK4 has not yet been reported. Thus, this study aimed to identify the residues in the baimantuoluoamide A and baimantuoluoamide B-CDK4 binding interface. For this purpose, molecular docking, molecular dynamics (MD) simulations and the MM/GBSA method to identify the binding modes and crucial residues were employed. The results obtained in the current study will provide valuable guidelines for developing novel potent and selective CDK4 inhibitors.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti, Farmacija
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus